FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileGenetic Signatures Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
GSS.AX
Genetic Signatures Limited Stock AnalysisComprehensive stock analysis for Genetic Signatures Limited (GSS.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGSS.AX
GSS.AX
Genetic Signatures Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
GSS.AX
  1. Home
  2. Stocks
  3. Genetic Signatures Limited

Genetic Signatures Limited

🇦🇺GSS.AX•ASX

Genetic Signatures Limited

🇦🇺GSS.AX•ASX

Your view on GSS.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Genetic Signatures Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Maria Halasz
Headquarters
Heart Research Institute, Newtown, NSW, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Maria Halasz
Headquarters
Heart Research Institute, Newtown, NSW, AU
Description

Genetic Signatures Limited operates as a molecular diagnostics (MDx) enterprise, extending its reach across Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa.

The company engineers and manufactures an array of real-time Polymerase Chain Reaction (PCR)-based products, sold under the EasyScreen brand, for the identification of infectious diseases.

Moreover, it offers its proprietary MDx 3Base platform technology, enabling hospitals and pathology laboratories to conduct comprehensive screenings for diverse infectious pathogens.

Its offerings also encompass detection kits tailored for conditions such as gastrointestinal ailments, respiratory illnesses, sexual health concerns, antimicrobial resistance, meningitis, and tropical diseases. Founded in 2001, the firm is headquartered in Newtown, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Genetic Signatures Limited. Starting points for Genetic Signatures Limited: EPS -AUD 0.06, beta 0.54 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Genetic Signatures Limited. Genetic Signatures Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Genetic Signatures Limited. Trailing twelve-month EPS for Genetic Signatures Limited stands at -AUD 0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Genetic Signatures Limited. Genetic Signatures Limited has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold GSS.AX12 companies
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
VCYTVeracyte, Inc.HealthcareNASDAQ$2.1B
VIMGFVimian Group AB (publ)HealthcareOTC$1.5B
VRCDFVerici Dx plcHealthcareOTC$4.5M
WATWaters CorporationHealthcareNYSE$45.8B
WGSGeneDx Holdings Corp.HealthcareNASDAQ$1.6B
WUXAYWuXi AppTec Co., Ltd.HealthcareOTC$45.6B
WUXIFWuXi AppTec Co., Ltd.HealthcareOTC$39.8B
XGNExagen Inc.HealthcareNASDAQ$99.5M
SKHHYSonic Healthcare LimitedHealthcareOTC$8.2B
SLDXStella Diagnostics Inc.HealthcareOTC$1.4M
SPDESpeedus Corp.HealthcareOTC$416
SZLSFStageZero Life Sciences Ltd.HealthcareOTC$61,766
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Genetic Signatures Limited. Coverage tracks Genetic Signatures Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Genetic Signatures Limited.

GSS.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1

News

Latest Market News